Atea Pharmaceuticals, Inc.

Direct answer

Atea Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker AVIR.

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company also developing...

Can you invest in Atea Pharmaceuticals, Inc.?

Yes. Atea Pharmaceuticals, Inc. trades publicly on NASDAQ as AVIR.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Atea Pharmaceuticals, Inc.

Detailed equity research is provided by MarketSnap.